人类胎盘基因CpG岛甲基化水平与自然流产的相关性

目的探讨人类胎盘基因CpG岛甲基化水平与孕妇自然流产的相关性。方法选取接受常规产前检查的孕妇55例为研究对象,其中25例自然流产(流产组),30例正常分娩(对照组)。收集入组孕妇的临床资料及人类胎盘组织样本。比较2组临床一般资料。分析相关胎盘基因的甲基化水平对孕妇自然流产结局的预测价值。采用Logistic回归分析法分析孕妇自然流产的影响因素。结果2组在孕妇年龄、流产儿/新生儿出生体质量、孕妇妊娠天数和流产儿/新生儿性别方面比较,差异有统计学意义(P<0.05)。MECP2-1、MECP2-4、HSD11B2、MECP2-3和MECP2-2基因甲基化与自然流产相关。流产组的MECP2-1、MECP2-4、HSD11B2和MECP2-3基因甲基化率高于对照组,差异有统计学意义(P<0.05)。MECP2-1、MECP2-4、HSD11B2、MECP2-3和MECP2-2的曲线下面积(AUC)分别为0.773、0.737、0.700、0.663和0.627。Logistic回归分析结果显示,MECP2-1是孕妇发生流产的独立影响因素(P<0.05)。结论MECP2-1、MECP2-4、HSD11B2、MECP2-3和MECP2-2基因甲基化水平和孕妇的自然流产结局有关。MECP2-1基因是自然流产发生的独立影响因素。

Genetic Behaviour of Bacterial Wilt Resistance in Brinjal (Solanum melongena L.) in Tropics of Andaman and Nicobar Islands of India

Brinjal or eggplant (Solanum melongena L.) is severely affected by bacterial wilt caused by Ralstonia solanecearum in Andaman and Nicobar Islands. Resistant varieties are most suitable option to reduce crop losses from bacterial wilt but knowledge of resistance mechanism and its inheritance is important to develop resistant varieties. Further, majority of germplasm from mainland India showed susceptible reaction under Andaman conditions. Thus, the present study was done during 2010-2012 to understand the genetic behaviour of bacterial wilt resistance in brinjal “CARI-B-1” (R) × “Pusa Purple Long” (S) in hot humid tropical climate of Andaman Islands. For this, the population from single F1 fruit was advanced to F2 and F3 and recorded the reaction of segregating population in the sick plots. The results revealed that there is preponderance of recessive gene family wherein more than one gene acts in additive mode. Another cross between S. torvum (R) × Diglipur local collection (S) also showed the recessive gene action for resistance as observed in F2 generation. Besides, the study also advocated that mechanisms of resistance, escape with early resistance and progressive escape have been found to be operating in individuals of segregating population.

Nucleosome Positions and Differential Methylation Status of Various Regions within MLH1 CpG Island

Objective： To determine the relationship between nucleosome positions and formation of differential methylation of the reported region A, B, C, and D within the MLH1 CpG island. Methods： Methylation of the MLH1 promoter was analyzed by combined of bisulfite restriction assay. Chromatin of RKO and MGC803 cells were extracted and digested by MNase. Mononucleosomal DNA fragment was isolated and used as templates for detection of nucleosomal distribution by a battery of quantitative PCRs covering the full MLH1 promoter region. Results： The MLH1 was methylated in RKO and unmethylated in MGC803. At the region B, where methylation of CpG sites did not correlated with transcription of this gene well, qPCR product of the M-3 （-599nt ～ -475nt） fragment was amplified in both RKO and MGC803 cells. However, at the region C and D within the core promoter, where methylation of CpG sites correlated with loss of MLH1 transcription well, the M-7 （-257nt ～ -153nt） and M-8 （-189nt ～ -71nt） fragments were amplified remarkably only in RKO cells. Conclusion： Nucleosome may be the basic unit for both CpG methylation and methylation-related regulation of gene transcription. Methylation status of CpG sites within the same nucleosome may be homogeneous; between different nucleosomes, homogeneous or heterogeneous.

CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis

AIM:To evaluate the clinical significance of CpG island methylator phenotype(CIMP) in plasma and its asso-ciation with hepatocellular carcinoma(HCC) progress.METHODS:CIMP status of 108 HCC patients wasanalyzed using a methylation marker panel in tumortissues and plasma with methylation-specific poly-merase chain reaction. Fifteen samples of non-neo-plastic liver tissues and 60 of plasma from healthy persons were examined simultaneously. Examinedgenes included APC,WIF-1,RUNX-3,DLC-1,SFRP-1,DKK and E-cad .RESULTS:The frequencies of high-level methylation in HCC tissue and plasma were at least 15% forthe seven genes:APC,48/108,44.44% in tissue and26/108,24.07% in plasma;WIF-1,53/108,49.07% intissue and 35/108,32.41% in plasma;RUNX-3,52/108,48.14% in tissue and 42/108,38.89% in plasma;DLC-1,38/108,35.18% in tissue and 23/108,21.30%in plasma;SFRP-1,40/108,37.04% in tissue and31/108,28.7% in plasma;DKK,39/108,36.1% in tis-sue and 25/108,23.14% in plasma;and E-cad,37/108,34.3% in tissue and 18/108,16.67% in plasma. CIMP+(≥ 3 methylated genes) was detected in 68(60.2%) tumor tissue samples and 62(57.4%) plasma samples.CIMP was not detected in non-neoplastic liver tissuesor plasma of healthy persons. CIMP status in tumortissues differed significantly in gender,hepatitis Bsurface antigen,alpha-fetoprotein,and tumor-node-metastasis stage(P < 0.05) . Similar results were obtained with plasma samples(P < 0.05) . There was nodifference in CIMP status in age,presence of hepatitis C virus antibody,cirrhosis,number of nodes,numberof tumors,tumor size,or Edmondson-Steiner stage. Aone-year follow-up found that the metastatic rate and recurrence rate in the CIMP+ group were significantly higher than in the CIMP- group as assessed with plasma samples(P < 0.05) .CONCLUSION:Plasma DNA can be a reliable samplesource for CIMP analysis. CIMP in plasma may serve asa molecular marker of late-stage and poor-prognosis HCC.

CpG island methylator phenotype and Helicobacter pylori infection associated with gastric cancer

AIM:To investigate the association between the CpG island methylator phenotype(CIMP) and serum Helicobacter pylori(H.pylori) levels for clinical prediction of gastric cancer(GC) progression.METHODS:We analyzed the serum CIMP status of 75 patients with GC using a methylation marker panel and a methylation-specific polymerase chain reaction.Serum samples from 40 healthy persons were examined at the same time.The genes examined were APC,WIF-1,RUNX-3,DLC-1,SFRP-1,DKK and E-cad.H.pylori infection in serum was assayed with an anti-H.pylori immunoglobulin G antibody test and a rapid urease test.RESULTS:The frequencies of high-level methylation in GC tissues for the seven genes were:48% for APC,57.33% for WIF-1,56% for RUNX-3,50.67% for DLC-1,52% for SFRP-1,54.67% for DKK,and 48% for E-cad.The frequencies in GC serum were 30.67% for APC,34.67% for WIF-1,37.33% for RUNX-3,29.33% for DLC-1,33.33% for SFRP-1,32% for DKK,and 26.67% for E-cad.CIMP+(defined as ≥ 3 methylated genes) was associated with 47(62.67%) GC tissue samples and 44(58.67%) GC serum samples.CIMP+ was not associated with non-neoplastic mucosal tissues or the serum of healthy persons.Of the 75 GC cases,51(68%) were H.pylori +,and 24(32%) were H.pylori-.Of the 51 H.pylori + cases,36 were CIMP+ and 15 were CIMP-.In contrast,for the 24 H.pylori-cases,11 were CIMP+,and 13 were CIMP-.The difference was significant between the H.pylori + and H.pylori-groups(χ 2 = 4.27,P < 0.05).Of the 51 H.pylori + GC patients,34 were CIMP+ and 17 were CIMP-,while among the 24 H.pylori-GC cases,10 were CIMP+ and 14 were CIMP-.The difference was significant between the H.pylori+ and H.pylori-groups(χ 2 = 4.21,P < 0.05).A 2-year follow-up showed significant difference in the rates of metastasis and recurrence between H.pylori +/CIMP+ cases and the H.pylori +/CIMP-cases or CIMP-cases associated with H.pylori assayed in serum(P < 0.05).However,there were no significant differences in survival rates between the two groups.CONCLUSION:H.pylori +/CIMP+ cases are associated with higher rates of metastasis and recurrence than H.pylori +/CIMP-cases.Serum may be useful for examining CIMP status.

Extramural vascular invasion and response to neoadjuvant chemoradiotherapy in rectal cancer: influence of the CpG island methylator phenotype

AIM To identify whether Cp G island methylator phenotype(CIMP) is predictive of response to neoadjuvant chemoradiotherapy(NACRT) and outcomes in rectal cancer.METHODS Patients undergoing NACRT and surgical resection for rectal cancer in a tertiary referral centre between 2002-2011 were identified. Pre-treatment tumour biopsies were analysed for CIMP status(high, intermediate or low) using methylation specific PCR. KRAS and BRAF status were also determined using pyrosequencing analysis. Clinical information was extracted from case records and cancer services databases. Response to radiotherapy was measured by tumour regression scores determined uponhistological examination of the resected specimen. The relationship between these molecular features, response to NACRT and oncological outcomes were analysed.RESULTS There were 160 patients analysed with a median followup time of 46.4 mo. Twenty-one(13%) patients demonstrated high levels of CIMP methylation(CIMP-H) and this was significantly associated with increased risk of extramural vascular invasion(EMVI) compared with CIMP-L [8/21(38%) vs 15/99(15%), P = 0.028]. CIMP status was not related to tumour regression after radiotherapy or survival, however EMVI was significantly associated with adverse survival(P < 0.001). Intermediate CIMP status was significantly associated with KRAS mutation(P = 0.01). There were 14(9%) patients with a pathological complete response(pC R) compared to 116(73%) patients having no or minimal regression after neoadjuvant chemoradiotherapy. Those patients with pC R had median survival of 106 mo compared to 65.8 mo with minimal regression, although this was not statistically significant(P = 0.26). Binary logistic regression analysis of the relationship between EMVI and other prognostic features revealed, EMVI positivity was associated with poor overall survival, advanced "T" stage and CIMP-H but not nodal status, age, sex, KRAS mutation status and presence of local or systemic recurrence.CONCLUSION We report a novel association of pre-treatment characterisation of CIMP-H with EMVI status which has prognostic implications and is not readily detectable on pre-treatment histological examination.

Hypermethylation of CpG island in O^6-methylguanine-DNA methyltransferase gene was associated with K-rasG to A mutation in colorectal tumor

AIM: To investigate the functions of promoter hypermethylation of O6-methylguanine-DNA methyltransferase (MGMT) gene in colorectal tumorigenesis and progression.METHODS: The promoter hypermethylation of MGMT gene was detected in 27 sporadic colorectal adenomas,62 sporadic colorectal carcinomas and 20 normal colorectal mucosa tissues by methylation-specific PCR. At the same time, the expression of MGMT protein was carried out in the same samples using immunohistochemistry. Mutantallele-specific amplification was used to detect K-rasG to A point mutation in codon 12.RESULTS: None of the normal colorectal mucosa tissues showed methylated bands. Promoter hypermethylation was detected in 40.7% (11 of 27) of adenomas and 43.5% (27 of 62) of carcinomas. MGMT proteins were expressed in nucleus and cytoplasm of normal colorectal mucosa tissues. Loss of MGMT expression was found in 22.2% (6 of 27) of adenomas and 45.2% (28 of 62) of carcinomas. The difference between them was significant (P = 0.041). In the 6 adenomas and 28 carcinomas losing MGMT expression, 5 and 24 cases presented methylation,respectively (P = 0.027, P＜0.001). Thirteen of the 19 colorectal tumors with K-rasG to A point mutation in codon 12 had methylated MGMT(P = 0.011). The frequencies of K-rasG to A point mutation were 35.3% (12 of 34) and 12.7% (7 of 55) in tumors losing MGMT expression and with normal expression, respectively.CONCLUSION: Promoter hypermethylation and loss of expression of MGMT gene were common events in colorectal tumorigenesis, and loss of expression of MGMT occurs more frequently in carcinomas than in adenomas in sporadic patients. Hypermethylation of the CpG island of MGMT gene was associated with loss of MGMT expression and K-ras G to A point mutation in colorectal tumor. The frequency of K-ras G to A point mutation was increased in tumors losing MGMT expression. It suggests that epigenetic inactivation of MGMT plays an important role in colorectal neoplasia.

CpG island methylator phenotype in adenocarcinomas from the digestive tract:Methods,conclusions,and controversies

Over the last two decades, cancer-related alterations in DNA methylation that regulate transcription have been reported for a variety of tumors of the gastrointestinal tract. Due to its relevance for translational research, great emphasis has been placed on the analysis and molecular characterization of the CpG island methylator phenotype(CIMP), defined as widespread hypermethylation of CpG islands in clinically distinct subsets of cancer patients. Here, we present an overview of previous work in this field and also explore some open questions using crossplatform data for esophageal, gastric, and colorectal adenocarcinomas from The Cancer Genome Atlas. We provide a data-driven, pan-gastrointestinal stratification of individual samples based on CIMP status and we investigate correlations with oncogenic alterations, including somatic mutations and epigenetic silencing of tumor suppressor genes. Besides known events in CIMP such as BRAF V600 E mutation, CDKN2 A silencing or MLH1 inactivation, we discuss the potential role of emerging actors such as Wnt pathway deregulation through truncating mutations in RNF43 and epigenetic silencing of WIF1. Our results highlight the existence of molecular similarities that are superimposed over a larger backbone of tissue-specific features and can be exploited to reduce heterogeneity of response in clinical trials.

启动子上的增强子和CpG岛在转基因沉默和位置效应中的作用

目的探讨哺乳动物细胞表达载体启动子上增强子和CpG岛调控元件在转基因沉默和位置效应中的作用。方法应用带增强子的八聚体结合转录因子4(OCT4)基因启动子、带CpG岛的性别决定区Y框蛋白2(SOX2)基因启动子、带增强子和CpG岛的巨细胞病毒(CMV)基因启动子以及不含近端增强子和CpG岛的NANOG基因启动子构建哺乳动物细胞表达载体,并分别转染中国仓鼠卵巢细胞株CHO-K1细胞和人胚胎肾细胞(HEK293)。应用Image J软件中Mean算法计算OCT4、SOX2、CMV和NANOG基因启动子在CHO-K1细胞和HEK293细胞介导的增强绿色荧光蛋白(EGFP)表达的荧光强度,应用Image J软件中Mininum、Maxentropy、Mean 3种算法分别计算OCT4、SOX2、CMV和NANOG基因启动子4种载体稳定转染CHO-K1细胞后形成的多个单细胞克隆混合生长样品在同一个样本中最大荧光强度的细胞、大于平均荧光强度的所有细胞和最小荧光强度的所有细胞的EGFP平均荧光强度;应用有限稀释法从G418筛选后获得的稳定转染的多个单克隆混合的CHO-K1细胞中,分别筛选含EGFP的pE-C1、pE-Oct4、pE-Sox2、pE-Nanog质粒稳定转染CHO-K1细胞的单克隆细胞,每个质粒载体随机筛选3个单克隆细胞,应用Image J软件分析EGFP平均荧光强度;应用酶联免疫吸附法检测转染第20、30天CHO-K1细胞中EGFP蛋白表达水平,应用实时荧光定量聚合酶链式反应法检测转染第20、30天CHO-K1细胞中EGFP mRNA表达水平。结果SOX2基因启动子在CHO-K1细胞和HEK293细胞中介导表达的EGFP平均荧光强度比较差异无统计学意义(t=0.770,P>0.05)。OCT4、CMV、NANOG基因启动子在CHO-K1细胞中介导表达的EGFP平均荧光强度显著高于HEK293细胞(t=7.000、11.100、4.900,P<0.05)。SOX2基因启动子于转染第20、30天在CHO-K1细胞中介导表达的EGFP蛋白水平比较差异无统计学意义(t=0.330,P>0.05)。CMV基因启动子于转染第20天在CHO-K1细胞中介导表达的EGFP蛋白水平显著低于转染第30天(t=3.770,P<0.05);OCT4基因启动子于转染第20、30天在CHO-K1细胞中介导表达的EGFP蛋白水平比较差异无统计学意义(t=2.500,P>0.05);NANOG基因启动子于转染第20、30天在CHO-K1细胞中介导表达的EGFP蛋白表达水平比较差异无统计学意义(t=0.014,P>0.05)。转染第20天与转染第30天SOX2、CMV、NANOG基因启动子在CHO-K1细胞中介导表达的EGFP平均荧光强度值比较差异均无统计学意义(t=0.130、0.830、0.210,P>0.05);转染第30天,OCT4基因启动子在CHO-K1细胞中介导表达的EGFP平均荧光强度值显著低于转染第20天(t=5.750,P<0.05)。SOX2、CMV、OCT4、NANOG基因启动子在CHO-K1细胞中介导表达的EGFP蛋白水平比较差异无统计学意义(F=4.070,P>0.05)。CMV、OCT4、NANOG基因启动子在CHO-K1细胞中介导的EGFP mRNA相对表达量显著高于SOX2基因启动子(t=5.440、5.000、5.740,P<0.05);CMV、OCT4基因启动子在CHO-K1细胞中介导的EGFP mRNA相对表达量显著高于NANOG基因启动子(t=3.220、4.270,P<0.05);CMV基因启动子在CHO-K1细胞中介导的EGFP mRNA相对表达量高于OCT4基因启动子,但差异无统计学意义(t=1.270,P>0.05)。SOX2基因启动子介导表达的EGFP在转录水平和转录后水平差异最大(t=16.900,P<0.05);NANOG基因启动子介导表达的EGFP在转录水平和转录后水平差异次之(t=14.930,P<0.05);OCT4和CMV基因启动子介导表达的EGFP在转录水平和转录后水平差异最小(t=2.060、0.430,P>0.05)。应用Mininum、Maxentropy、Mean 3种算法计算OCT4基因启动子在多克隆下介导表达的EGFP的荧光强度比较差异无统计学意义(F=3.720,P>0.05),SOX2、CMV和NANOG基因启动子在多克隆下介导EGFP表达的荧光强度比较差异均有统计学意义(F=516.400、428.500、28.120,P<0.05)。不同单克隆细胞中的差异分析显示,4种载体在不同单克隆细胞中介导表达的EGFP荧光强度值的标准误差相比,从高到低依次为NANOG基因启动子在不同单克隆细胞中介导表达的EGFP荧光强度值标准误差、SOX2基因启动子在不同单克隆细胞中介导表达的EGFP荧光强度值标准误差、OCT4基因启动子在不同单克隆细胞中介导表达的EGFP荧光强度值标准误差、CMV基因启动子在不同单克隆细胞中介导表达的EGFP荧光强度值标准误差,且OCT4基因启动子与SOX2、CMV基因启动子在单克隆细胞中介导表达的EGFP平均荧光强度比较差异有统计学意义(t=3.070、4.360,P<0.05)。结论带CpG岛的启动子能在转录后克服转基因沉默效应,带增强子的启动子具有克服位置效应的作用;二者的恰当组合可用于设计在哺乳动物细胞中高效稳定表达的启动子。

Design Optimization of CFRP Stacking Sequence Using a Multi-Island Genetic Algorithms Under Low-velocity Impact Loads

A method to improve the low-velocity impact performance of composite laminate is proposed, and a multi-island genetic algorithm is used for the optimization of composite laminate stacking sequence under low-velocity impact loads based on a 2D dynamic impact finite element analysis. Low-velocity impact tests and compression-after impact（CAI） tests have been conducted to verify the effectiveness of optimization method. Experimental results show that the impact damage areas of the optimized laminate have been reduced by 42.1% compared to the baseline specimen, and the residual compression strength has been increased by 10.79%, from baseline specimen 156.97 MPa to optimized 173.91 MPa. The tests result shows that optimization method can effectively enhance the impact performances of the laminate.

Effect of Isolation of Hainan Island from the Mainland on the Genetic Variation of Podocarpus imbricatus

Random amplified polymorphic DNA (RAPD) markers were used to analyze genetic variation of Podocarpus imbricatus in Hainan Island and Mainland of China. Two populations of Dacrydium pierrei were used as comparison materials. Both Podocarpus imbricatus and Dacrydium pierrei showed a low level of genetic diversity. However, Podocarpus imbricatus showed higher genetic diversity and higher population differentiation than Dacrydium pierrei. The geographic range may affect the genetic diversity of Podocarpus imbricatus and Dacrydium pierrei significantly. The UPGMA cluster tree showed that populations of Podocarpus imbricatus in Hainan Island and Guangxi Zhuang Autonomous Region were closer than those in Yunnan Province, indicating possible gene flow between Hainan Island and Guangxi Zhuang Autonomous Region. The young geological history of Hainan Island and the three times of unification and separation between Hainan Island and the Mainland may give the two species more possibilities of gene flow.

中国碳酸盐岩油气勘探与白云岩研究最新成果:第17届全国古地理学及沉积学学术会议成果综述

简述了第17届全国古地理学及沉积学大会碳酸盐岩油气勘探、白云岩、深层碳酸盐岩尤其是白云岩成因理论研究新成果。统计含55个口头报告和15个展板;涉及塔里木、四川、鄂尔多斯、柴达木、吐哈和渤海湾等盆地白云岩成因与成储;深层、万米超深层白云岩规模储集层形成、表征和保存机制;生物岩和碳酸盐岩形成过程的定量评价等。值得推荐10000 m超深层白云岩优质储集层特征和成因机制研究,坚持提出万米超深层白云岩勘探建议,成为白云岩成因理论研究指导生产实践的代表性成果,是2022年国际沉积学大会及近年国际白云岩成因基础研究成果应用薄弱环节补充;有关四川盆地深层白云岩储集层特征和成因机制的研究来自不同院校项目成果的总结。提出了深层白云岩成因成储、万米超深层白云岩优质储集层评价与勘探理论;尤其激光剥蚀等离子体质谱U-Pb定年技术得到普遍应用,实现了地质时期白云化作用特征和成因机制的定性定量分析;生物岩的讨论颇具特色;这些内容分别代表沉积学—岩相古地理学—矿物岩石学—新技术和白云岩成因理论研究与实际应用紧密结合成果,总体创新深度、研究手段、系统理论和在油气勘探部署中的应用特征显著,是本次学术会议亮点。不足之处:仅见1篇海洋岛礁白云岩论文出现在展板中,预期18届克拉玛依会议将进一步深化上述领域的研究,海洋岛屿白云岩研究专题将备受重视。

面向壁厚均匀的液压成形三通管的坯料设计方法与参数优化

目的研究连续变厚度管液压成形过程中三通管的壁厚均匀性问题。方法首先,利用有限元软件分析得到了等厚管液压成形三通管过程中的成形规律,根据其成形规律,反向设计了用于液压成形三通管的连续变厚度管坯;其次,采用正交试验方法,研究了连续变厚度管厚区壁厚、过渡区长度对液压成形三通管成形质量的影响;最后,采用多岛遗传算法,对连续变厚度管的结构参数进行了优化验证,提高了液压成形三通管的成形质量。结果在等厚管液压成形三通管成形过程中,支管顶部壁厚值持续减小、轴向过渡圆角及直管底部中间位置处壁厚值持续增大;环向过渡圆角处等效应力最大,其他位置连续变化;轴向压应力使得三通管壁厚增大,拉应力使得壁厚减小;正交试验结果表明,当连续变厚度管厚区厚度、环向过渡区长度达到某一值时将出现较好的壁厚均匀性;在4种过渡区曲线线型中,直线型的壁厚均匀性最好;通过多目标优化得到最佳连续变厚度管结构参数,并通过有限元仿真进行验证,相对误差均在2%以内,使用优化后的连续变厚度管液压成形三通管相对于等厚管,壁厚均匀值减小了0.423 mm。结论可以采用厚度补偿或减薄的方式来提高成形三通管的壁厚均匀性;连续变厚度管坯相比于等厚管,显著提高了液压成形三通管的壁厚均匀性。

自由曲面轮廓仪机架多目标优化设计

针对复杂机床结构优化过程中,通常难以处理各个设计参数之间的关联关系的问题,提出了一种结合数值模拟和优化算法进行多目标优化设计的方法。在Isight平台中调用SolidWorks和Workbench插件进行试验设计,通过最优拉丁超立方试验设计方法(optimal latin hypercube algorithm,OLHA)设计样本点,用生成的样本点构建泛克里金近似模型,并使用交叉验证证明模型的可靠性和有效性,以最大位移变形量最小和一阶固有频率最大为优化目标,运用多岛遗传算法(multi-island genetic algorithm,MIGA)进行寻优计算来获取最优解。优化后的一阶固有频率为221.31 Hz,较优化前增加了8.43%,最大变形为0.001 888 mm,减小了18.45%,实现了机架的多目标优化设计。

基于Isight的增程式电动汽车定点控制策略优化

基于专家经验和工程经验制定的传统规则能量管理策略并不能适应当前增程式汽车复杂的行驶工况,为了更加精确地控制增程式汽车,使其获得更好的燃油经济性,考虑到增程器中发动机定点控制策略的发动机工作点切换规则影响,采用Cruise建立整车模型、Isight对其参数进行优化的方式探究发动机工作点切换规则对油耗的影响,比较其百公里油耗。研究结果表明,优化后NEDC工况、WLTC工况、混合工况的百公里燃油消耗量分别降低了3.51%、7.3%、8.5%,为增程式汽车定点控制策略优化提供了一种新方法,并验证了其可行性。

ABO基因启动子CpG岛甲基化与白血病的相关性

近年来研究发现ABO血型与许多疾病的发生发展相关,某些肿瘤导致A、B血型物质减少的现象已日益引起关注。本研究探讨ABO基因启动子CpG岛甲基化与白血病的相关性。采用流式细胞仪和激光共聚焦显微镜检测了不同血型的健康人群和各种血液病患者外周血红细胞表面ABH抗原的相对含量,用PCR和MSP-PCR分别检测血液病患者和健康人ABO基因启动子DNA序列和CpG岛甲基化,以及ABO基因启动子-102位点的甲基化。结果发现,白血病患者均出现不同程度的A、B抗原减少;通过对比检测健康人和患者的ABO基因启动子序列,未发现有序列的不同,说明启动子序列高度保守;利用重亚硫酸盐对DNA样本进行修饰后,通过对健康人和患者的ABO基因启动子序列进行扩增和测序,发现健康人和再生障碍性贫血患者在ABO基因启动子的CpG岛区没有甲基化的位点,而急性髓性白血病(AML)、急性淋巴细胞白血病(ALL)、慢性粒细胞白血病(CML)和部分骨髓增生异常综合征(MDS)患者在位置为-102、-101、-100、-99和-97位置的C碱基均有甲基化的现象。结论:甲基化是造成白血病患者AB抗原下降的原因;-102、-101、-100、-99和-97这几个甲基化位点有可能是白血病的特异性表现;针对-102位点检测结果提示-102位点是否甲基化有可能作为白血病鉴别诊断中一个有意义的分子标识物。

CpG岛甲基化表型及OPCML基因甲基化与肝细胞癌发生的关系

背景与目的:CpG岛甲基化表型(CpGislandmethylatorphenotype,CIMP)涉及到多个基因启动子同时甲基化,具有肿瘤特异性,与多种肿瘤的发生或预后相关,但有关肝癌CPG岛甲基化表型的研究罕见报道。OPCML(opioid-bindingprotein/celladhesionmolecule-like)基因目前多为针对上皮性卵巢癌的研究,被认为是卵巢癌的候选抑癌基因。本研究旨在探讨CIMP及OPCML基因与肝癌的发生是否有关。方法:运用甲基化特异性PCR方法检测50例肝细胞癌组织及48例癌旁组织中OPCML、p15、SOCS-1、GST-p、RAR-b、p16、p73、p14、MGMT和hMLH1基因的甲基化状况。结果:肝癌组织甲基化率普遍比相应癌旁组织甲基化率高:OPCML(70.0%vs.64.6%)、p15(58.0%vs.50.0%)、SOCS-1(78.0%vs.50.0%)、GST-p(56.0%vs.27.1%)、RAR-b(30.0%vs.6.3%)、p16(26.0%vs.14.6%)、p73(16.0%vs.0%)、p14(36.0%vs.27.1%)、MGMT(16.0%vs.10.4%)和hMLH1(18.0%vs.4.2%)。SOCS-1,GST-p,RAR-b,p16和p73基因甲基化率在肝癌组与癌旁组差异有显著性(P<0.05),其它基因两组之间的甲基化率差异无显著性。CIMP阳性组(同时具有≥3个位点甲基化)复发时间较早,1年无瘤生存率为18.2%,而CIMP阴性组(具有<3个位点甲基化)复发时间较晚,1年无瘤生存率为75.0%(P<0.05)。结论:肝癌中存在着CpG岛甲基化表型(CIMP),CIMP可作为肝癌患者预后判断的指标之一;OPCML基因甲基化可能在肝癌的发生中发挥重要的作用。

人原发性肝癌中p16基因表达及CpG岛甲基化状态的研究

目的 进一步探讨人原发性肝癌中 p16基因 m RNA转录水平变化与其基因启动子区 Cp G岛甲基化的关系 ,及其在肝癌发生中的意义。方法 采用狭缝印迹杂交检测 2 0例人原发性肝癌及相应的癌旁、远癌组织及 2例正常人肝组织中 p16基因 m RNA表达水平 ,以甲基化特异性 PCR分析各组织中 p16基因启动子区 Cp G岛的甲基化状况 ,并进行统计分析。结果 2 0例人原发性肝癌中 14例 (70 % ) p16 m RNA水平比远癌组织显著降低 ;13例 (6 5 % )显示 p16基因启动子区 Cp G岛甲基化 ,其中 84 .6 % (11例 )伴 p16 m RNA转录水平降低。结论 人原发性肝癌中存在高频率的 p16基因表达失活 ,其主要机制可能是启动子区 Cp G岛甲基化抑制了基因的转录 ,在人原发性肝癌的发生发展中有重要作用。其临床诊断和治疗意义有待进一步深入研究。

恶性血液病细胞系分泌型卷曲相关蛋白基因启动子CpG岛甲基化状态的检测及意义

为了研究分泌型卷曲相关蛋白(secreted frizzled-related protein,SFRP)家族基因启动子CpG岛的甲基化状态,探讨SFRP基因启动子区CpG岛的异常甲基化状态与恶性血液病发病机制的可能联系,采用甲基化特异性PCR(Methylation-specific PCR,MSP)的方法检测了9种恶性血液病细胞系及正常人外周血单个核细胞中SFRP基因启动子区的甲基化状态。结果显示:9种恶性血液病细胞系中SFRP1、2基因启动子区均呈高甲基化状态,CA46、HL60和U937细胞中的SFRP4基因以及U266细胞中的SFRP5基因启动子区呈部分甲基化状态,其他细胞系SFRP4、5基因启动子均呈完全甲基化状态。正常人外周血单个核细胞中SFRP1、2、4、5基因启动子区均呈非甲基化状态。结论:SFRP基因启动子区异常甲基化模式与恶性血液病的发生密切相关。SFRP基因启动子区的甲基化状态有可能成为恶性血液病新的分子诊断标记物。

胃癌E-cadherin基因启动子CpG岛甲基化的研究

背景与目的:目前认为CpG岛甲基化导致转录抑制是恶性肿瘤发生的重要机制之一。E-cadherin能抑制肿瘤细胞的浸润和转移,被公认为是浸润、转移抑制基因。低分化胃癌常表现有E-cadherin基因失活。我们通过检测胃癌及癌旁组织中E-cadherin基因启动子CpG岛甲基化水平,初步探讨胃癌的发病机制。方法:采用特异性甲基化PCR(MSP)法检测51例胃癌组织及37例癌旁组织中的E-cadherin基因启动子CpG岛甲基化水平,采用免疫组织化学染色法检测E-cadherin表达。结果:健康对照组织中未检测到CpG岛甲基化,4例(10.8%)癌旁组织检测到CpG岛甲基化,32例(62.7%)胃癌组织中检测到CpG岛甲基化。低分化腺癌(72.2%,26/36)CpG岛甲基化显著高于高分化腺癌(33.3%,6/15)(P<0.01),T1/T2期(55.6%,10/18)与T3/T4期胃癌(66.7%,22/33)的CpG岛甲基化率无显著性差异(P>0.05)。32例CpG岛甲基化胃癌中27例(84.5%)E-cadherin表达下调,19例非甲基化胃癌中5例(26.3%)E-cadherin表达下调。未发现E-cadherin基因CpG岛甲基化与幽门螺杆菌感染有关。结论:胃癌、尤其是低分化腺癌广泛存在E-cadherin基因启动子CpG岛甲基化,启动子CpG岛甲基化可能参与胃癌的早期过程,E-cadherin基因CpG岛甲基化与幽门螺杆菌感染无相关关系。